TOMASZ SABLINSKI TOPS “CHAMPIONS OF CHANGE” IN THE MEDICINE MAKER’S 2018 POWER LIST

Experience the Future of Clinical Trials Now

Patient convenience and our cloud-based platform enable clinical trial sponsors to achieve better results at lower cost.

The world’s first digital drug development services company

Transparency Life Sciences is the first all-digital drug development services company. Our crowdsourcing software and mobile health technology enable drug candidates to advance through clinical trials with unprecedented patient convenience, data relevance, efficiency and affordability.

View News

Transparency Digital Solutions

Our platform is an all-digital solution that facilitates development of new drugs with more informative data and optimized labels, and produces successful clinical trials with faster timelines and smaller budgets.

Transparency Protocol Crowdsourcing
Transparency
Virtual Trials
Transparency Personalized Digityping

Our online, crowdsourced approach to clinical protocol design helps craft study protocols co-designed by patients and physicians that are relevant to real-world medical needs
Learn More

Our virtual trial hub integrates telemedicine, mobile health and cloud technology to run trials that are simpler for everyone and result in faster, more cost-effective delivery
Learn More

Our approach to personalized patient digital phenotyping, ‘digityping’ for short, uses mobile health technology to identify and stratify the right participants for each clinical trial
Learn More

Project Highlights

Browse below to find a Protocol Builder to participate in, or to see if a study you’re interested in is enrolling patients. Check back often since new projects will be added frequently.

Transparency Protocol Crowdsourcing

Our online, crowdsourced approach to clinical protocol design helps craft study protocols co-designed by patients and physicians that are relevant to real-world medical needs
Learn More

Transparency
Virtual Trials

Our virtual trial hub integrates telemedicine, mobile health and cloud technology to run trials that are simpler for everyone and result in faster, more cost-effective delivery
Learn More

Transparency Personalized Digityping

Our approach to personalized patient digital phenotyping, ‘digityping’ for short, uses mobile health technology to identify and stratify the right participants for each clinical trial
Learn More

Trusted for unparalleled relevance and efficiency

“We applaud Transparency Life Sciences for being a valued partner of our Foundation, and for creating a model in which patients are more than subjects, but thoughtful collaborators in clinical trial design and execution.”

– Ginger Spitzer, Executive Director, Foundation for Sarcoidosis Research

“Transparency Life Sciences’ crowdsourcing expertise obtained fresh insights for our protocol assessing metformin in prostate cancer. Their commitment to all-digital clinical trials will benefit patients and investigators, and help achieve more efficient and more informative clinical trials.”

– Dr. Matthew Galsky, Professor of Hematology-Oncology, Mt. Sinai School of Medicine

“Transparency Life Sciences pioneered open sourcing design of clinical trial protocols and was one of the first to execute ‘virtual’ studies; implementation of their model will enable true patient centric clinical research.”

– Jeffrey Kasher, President, Patients Can't Wait, LLC; former VP and COO, Global Clinical Development Organization, Eli Lilly and Company

Trusted for unparalleled relevance and efficiency

“We applaud Transparency Life Sciences for being a valued partner of our Foundation, and for creating a model in which patients are more than subjects, but thoughtful collaborators in clinical trial design and execution.”

– Ginger Spitzer, Executive Director, Foundation for Sarcoidosis Research

“Transparency Life Sciences’ crowdsourcing expertise obtained fresh insights for our protocol assessing metformin in prostate cancer. Their commitment to all-digital clinical trials will benefit patients and investigators, and help achieve more efficient and more informative clinical trials.”

– Dr. Matthew Galsky, Professor of Hematology-Oncology, Mt. Sinai School of Medicine

“Transparency Life Sciences pioneered open sourcing design of clinical trial protocols and was one of the first to execute ‘virtual’ studies; implementation of their model will enable true patient centric clinical research.”

– Jeffrey Kasher, President, Patients Can't Wait, LLC; former VP and COO, Global Clinical Development Organization, Eli Lilly and Company

2012
2013
2014
2015
2016
2017
2012

Company launches 1st crowdsourcing project

TLS launches 1st project, a repurposing study of lisinopril in MS. This crowdsourcing campaign provides crucial input in selecting the study’s endpoint.

2013

An industry first: TLS receives IND clearance for 1st crowdsourced protocol

TLS begins collaboration with Genentech and Brigham & Women’s Hospital on ulcerative colitis study.

2014

1st patient enrolls in a crowdsourced clinical study

TLS crowd-designed prostate cancer study at Mount Sinai Hospital enrolls 1st patient. TLS receives NIH SBIR funding to execute digital trial of lisinopril.

2015

Pre-IND FDA meeting for all-digital study

TLS participates in pre-IND meeting for all-digital trial for novel sarcoidosis drug. TLS enrolls 1st patient in its ulcerative colitis study.

2016

Technical Proof-of-Concept for Virtual Trials

The ulcerative colitis and multiple sclerosis trials were successfully completed through virtual administration. Final study reports were created from remotely collected data.

2017

Series A Financing

This funding fuels growth and allows TLS to continue to be a leader in digital drug development.

Project Highlights

View all projects  →

Browse below to find a Protocol Builder to participate in, or to see if a study you’re interested in is enrolling patients. Check back often since new projects will be added frequently.

All Projects
Kiacta in Sarcoidosis, Part II View Project
Lisinopril in Multiple Sclerosis View Project
Metformin in Prostate Cancer View Project
Telemedicine Acceptance in IBD View Project

Always stay in the loop.
Sign up for our newsletter for the latest project updates.